Medical Marijuana for Multiple Sclerosis in Washington State

Multiple sclerosis (MS) is one of Washington State's explicitly named qualifying conditions for medical marijuana. For MS patients dealing with spasticity, chronic pain, fatigue, and sleep disruption, cannabis has some of the strongest clinical evidence of any qualifying condition — including a completed randomized controlled trial from the UK showing significant spasticity reduction.

MS qualifies for Washington medical marijuana

Washington's medical cannabis statute (RCW 69.51A) lists multiple sclerosis by name. Any MS diagnosis — relapsing-remitting (RRMS), secondary progressive (SPMS), primary progressive (PPMS), or clinically isolated syndrome (CIS) — qualifies. You don't need to be at a specific disease stage or actively experiencing symptoms during your evaluation.

Related qualifying conditions that MS patients often also have:

• Chronic pain from nerve damage or muscle spasticity
• Intractable pain
• Glaucoma (less common, but some MS medications cause IOP changes)

How cannabis helps with MS symptoms

MS produces a wide range of symptoms, and cannabis addresses several of them through different mechanisms:

• Spasticity — the most evidence-backed use for cannabis in MS. Multiple clinical trials show significant reduction in muscle spasticity and associated pain. In the UK, Sativex (a cannabinoid mouth spray) is approved specifically for MS spasticity. Washington patients can access full-spectrum cannabis products with comparable cannabinoid profiles.
• Neuropathic pain — MS damages the myelin sheath that insulates nerves, causing burning, stabbing, and electric-shock pain that responds poorly to traditional analgesics. Cannabis, particularly products with both THC and CBD, shows strong evidence for this type of pain.
• Sleep disruption — pain and spasticity commonly disrupt MS patients' sleep. Cannabis can improve sleep quality and duration, which has downstream effects on fatigue and daytime function.
• Bladder dysfunction — MS often causes urgency and incontinence. Some studies suggest cannabis reduces bladder overactivity, though evidence is less robust than for spasticity.
• Fatigue — MS-related fatigue is one of the most disabling symptoms and one of the hardest to treat. Lower-dose cannabis products may reduce fatigue perception in some patients, though high-THC doses can worsen it.

Note: High-dose THC can temporarily worsen some MS symptoms for some patients, particularly balance and cognitive function. This is why individualized guidance from a knowledgeable provider matters.

What products work best for MS?

Your Green Wellness provider will give personalized recommendations at your evaluation. General approaches for MS symptoms:

• For spasticity — balanced THC:CBD tinctures or capsules taken at regular intervals rather than as-needed; some patients prefer vaporized products for faster onset during spasm episodes
• For neuropathic pain — CBD-dominant products during the day, with modest THC added in the evening when pain is often worst
• For sleep — indica-dominant products with higher THC taken 30–60 minutes before bed
• For fatigue — sativa-leaning, lower-THC products in the morning; avoid high-THC products if fatigue is a primary complaint

MS medications and cannabis interactions

Many MS patients are on disease-modifying therapies (DMTs) such as interferons, dimethyl fumarate (Tecfidera), natalizumab (Tysabri), or ocrelizumab (Ocrevus). Current evidence does not suggest cannabis significantly interferes with MS DMTs, but CYP450 interactions with some oral medications are possible. Your Green Wellness provider will review your medication list and flag any potential interactions.

Getting your authorization

With an MS diagnosis, your evaluation is typically brief and straightforward. Bringing a letter from your neurologist or a recent MRI report helps confirm the diagnosis, though it isn't required. Your Green Wellness provider will issue your authorization the same day.

Same-day appointments are available at all four Green Wellness locations — Lynnwood, Spokane, Olympia, and Vancouver. Telehealth is available for renewals and for patients with mobility limitations.

Book your MS evaluation — $175 →